Parkinson's disease - palliative care needs assessment tool: adaptation and psychometric testing
被引:3
|
作者:
Richfield, Edward William
论文数: 0引用数: 0
h-index: 0
机构:
North Bristol NHS Trust, Med Older People, Westbury On Trym BS10 5NB, EnglandNorth Bristol NHS Trust, Med Older People, Westbury On Trym BS10 5NB, England
Richfield, Edward William
[1
]
Allgar, Victoria
论文数: 0引用数: 0
h-index: 0
机构:
Plymouth Univ, Peninsula Clin Trials Unit, Plymouth, Devon, EnglandNorth Bristol NHS Trust, Med Older People, Westbury On Trym BS10 5NB, England
Allgar, Victoria
[2
]
Girgis, Afaf
论文数: 0引用数: 0
h-index: 0
机构:
Univ NSW, South Western Sydney Clin Sch, Sydney, NSW, AustraliaNorth Bristol NHS Trust, Med Older People, Westbury On Trym BS10 5NB, England
Girgis, Afaf
[3
]
Johnson, Miriam J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hull, Wolfson Palliat Care Res Ctr, Kingston Upon Hull, N Humberside, EnglandNorth Bristol NHS Trust, Med Older People, Westbury On Trym BS10 5NB, England
Johnson, Miriam J.
[4
]
机构:
[1] North Bristol NHS Trust, Med Older People, Westbury On Trym BS10 5NB, England
[2] Plymouth Univ, Peninsula Clin Trials Unit, Plymouth, Devon, England
[3] Univ NSW, South Western Sydney Clin Sch, Sydney, NSW, Australia
[4] Univ Hull, Wolfson Palliat Care Res Ctr, Kingston Upon Hull, N Humberside, England
Objective Parkinson's disease is a progressive, life-limiting disease, which benefits from structured palliative care. Systematic recognition and triage of needs helps facilitate care, allows focused referral to specialist palliative care and aids sustainability of services. Existing palliative care tools for Parkinson's are patient/caregiver completed and focus on quantification rather than identification of the need. The Needs Assessment Tool: Progressive Disease in Cancer was designed for rapid identification of unmet needs in cancer. We describe adaptation and psychometric testing of the tool for Parkinson's disease (NAT:Parkinson's disease). Methods Set in secondary care, Parkinson's disease outpatient clinics in the UK, this study included people with Parkinson's, age >18, including all disease stages. People with atypical Parkinsonian syndromes were excluded. Adaptation was made using systematic review and focus groups. Construct validity was tested in 50 consecutive patients against established patient and caregiver measures, analysed with Kendall's Tau B. Inter-rater reliability, using video consultations, were calculated in broad range of clinicians involved in Parkinson's disease care using a weighted kappa; 0-0.2=slight, 0.21-0.40=fair, 0.41-0.60=moderate, 0.61-0.80=substantial and p Results Validity was substantial for two, moderate for five and fair for four constructs. Inter-rater reliability was substantial for one, moderate for three and fair for six constructs. Two constructs failing to demonstrate fair reliability did show very high percentage agreement. Conclusion Findings support the suitability of the NAT:Parkinson's disease for everyday clinical use in the identification and triage of unmet palliative need for people with Parkinson's disease.